Recently Viewed

  • Home
  • Stories
  • News Announcement
  • Aurobindo Pharma: Information Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
News Announcement

Aurobindo Pharma: Information Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

01-Jul-2023 Follow Value Research Online on Google download pdfDownload PDF Aurobindo Pharma

Completion of sale and transfer of all equity shares held by Aurobindo Pharma Limited in Auro Vaccines Private Limited a WOS to CuraTeQ Biologics Private Limited another WOS.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.

Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month